Latest News & Updates
Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe
Panthera partnership with Preston North End Community Trust
Valneva vaccine clinical trial, phase 3 results
Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine to volunteers in COVID prevention study
Clinical trial specialist Panthera Biopartners has appointed corporate financier Christopher Steed as a non-executive director to continue its expansion both in the UK and overseas
